Corline Biomedical AB — Investor Relations & Filings

Corline Biomedical AB develops, manufactures, and markets heparin-based solutions that provide antithrombotic and anti-inflammatory properties. The company's core technology is the Corline Heparin Surface (CHS™), a proprietary surface coating for the medical device industry designed to improve biocompatibility and manage immune thrombosis. Corline also develops products for the regenerative medicine field, including Renaparin® and Cytoparin™, which are aimed at enhancing outcomes in applications such as kidney transplantation and cell therapies. The company's solutions target significant unmet clinical needs by reducing thrombotic and inflammatory complications when foreign materials or cells are introduced to the body.